SIGNR1-negative red pulp macrophages protect against acute streptococcal sepsis after Leishmania donovani-induced loss of marginal zone macrophages.

Marginal zone macrophages in the murine spleen play an important role in the capture of blood-borne pathogens and are viewed as an essential component of host defense against the development of pneumococcal sepsis. However, we and others have previously described the loss of marginal zone macrophages associated with the splenomegaly that follows a variety of viral and protozoal infections; this finding raises the question of whether these infected mice would become more susceptible to secondary pneumococcal infection. Contrary to expectations, we found that mice lacking marginal zone macrophages resulting from Leishmania donovani infection have increased resistance to Streptococcus pneumoniae type 3 and do not develop sepsis. Using biophotonic imaging, we observed that pneumococci are rapidly trapped in the spleens of L. donovani-infected mice. By selective depletion studies using clodronate liposomes, depleting monoclonal antibodies specific for Ly6C/G and Ly6G, and CD11c-DTR mice, we show that the enhanced early resistance in L. donovani-infected mice is entirely due to the activity of SIGNR1(-) red pulp macrophages. Our data demonstrate, therefore, that the normal requirement for SIGNR1(+) marginal zone macrophages to protect against a primary pneumococcal infection can, under conditions of splenomegaly, be readily compensated for by activated red pulp macrophages.

[1]  T. Junt,et al.  Restoration of lymphoid organ integrity through the interaction of lymphoid tissue–inducer cells with stroma of the T cell zone , 2008, Nature Immunology.

[2]  M. Litjens,et al.  Interaction of SIGNR1 expressed by marginal zone macrophages with marginal zone B cells is essential to early IgM responses against Streptococcus pneumoniae. , 2008, Molecular immunology.

[3]  Michael D. Connolly,et al.  Use of Ly6G‐specific monoclonal antibody to deplete neutrophils in mice , 2008, Journal of leukocyte biology.

[4]  J. Ceuppens,et al.  Specific Intracellular Adhesion Molecule-Grabbing Nonintegrin R1 Is Not Involved in the Murine Antibody Response to Pneumococcal Polysaccharides , 2007, Infection and Immunity.

[5]  R. Mebius,et al.  New Insights into the Cell Biology of the Marginal Zone of the Spleen , 2006, International Review of Cytology.

[6]  P. Kaye,et al.  Distinct roles for IL‐6 and IL‐12p40 in mediating protection against Leishmania donovani and the expansion of IL‐10+ CD4+ T cells , 2006, European journal of immunology.

[7]  B. Pulendran,et al.  Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. , 2006, The Journal of clinical investigation.

[8]  S. Straus,et al.  Causes and consequences of the autoimmune lymphoproliferative syndrome , 2006, Hematology.

[9]  P. Kaye,et al.  CD11b regulates recruitment of alveolar macrophages but not pulmonary dendritic cells after pneumococcal challenge. , 2006, The Journal of infectious diseases.

[10]  T. van der Poll,et al.  Specific ICAM‐3 grabbing nonintegrin‐related 1 (SIGNR1) expressed by marginal zone macrophages is essential for defense against pulmonary Streptococcus pneumoniae infection , 2005, European journal of immunology.

[11]  D. Golenbock,et al.  The Apoptotic Response to Pneumolysin Is Toll-Like Receptor 4 Dependent and Protects against Pneumococcal Disease , 2005, Infection and Immunity.

[12]  R. Zinkernagel,et al.  Histological analysis of CD11c‐DTR/GFP mice after in vivo depletion of dendritic cells , 2005, Clinical and experimental immunology.

[13]  P. Kaye,et al.  The role played by tumor necrosis factor during localized and systemic infection with Streptococcus pneumoniae. , 2005, The Journal of infectious diseases.

[14]  Lynette Beattie,et al.  The importance of the spleen in malaria. , 2005, Trends in parasitology.

[15]  Kenneth G. C. Smith,et al.  SIGN-R1 Contributes to Protection against Lethal Pneumococcal Infection in Mice , 2004, The Journal of experimental medicine.

[16]  P. Kaye,et al.  Localization of Marginal Zone Macrophages Is Regulated by C-C Chemokine Ligands 21/191 , 2004, The Journal of Immunology.

[17]  P. Kaye,et al.  The immunopathology of experimental visceral leishmaniasis , 2004, Immunological reviews.

[18]  R. Steinman,et al.  The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Han,et al.  Pneumococcal Lipoteichoic Acid (LTA) Is Not as Potent as Staphylococcal LTA in Stimulating Toll-Like Receptor 2 , 2003, Infection and Immunity.

[20]  S. Kaufmann,et al.  Macrophages of the Splenic Marginal Zone Are Essential for Trapping of Blood-Borne Particulate Antigen but Dispensable for Induction of Specific T Cell Responses , 2003, The Journal of Immunology.

[21]  R. Steinman,et al.  SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran. , 2003, International immunology.

[22]  M. Nolte,et al.  Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. , 2002, Blood.

[23]  Steffen Jung,et al.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. , 2002, Immunity.

[24]  P. Kaye,et al.  A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection. , 2002, The American journal of pathology.

[25]  Marc Lipsitch,et al.  Visualizing Pneumococcal Infections in the Lungs of Live Mice Using Bioluminescent Streptococcus pneumoniaeTransformed with a Novel Gram-Positive luxTransposon , 2001, Infection and Immunity.

[26]  F. Galeazzi,et al.  Inflammation-induced impairment of enteric nerve function in nematode-infected mice is macrophage dependent. , 2000, American Journal of Physiology - Gastrointestinal and Liver Physiology.

[27]  P. Kaye,et al.  Dendritic cells, but not macrophages, produce IL‐12 immediately following Leishmania donovani infection , 1998, European journal of immunology.

[28]  N. Van Rooijen,et al.  Elimination, blocking, and activation of macrophages: three of a kind? , 1997, Journal of leukocyte biology.

[29]  R. Zinkernagel,et al.  Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection , 1997, European journal of immunology.

[30]  J. Raynes,et al.  Acute phase protein concentrations predict parasite clearance rate during therapy for visceral leishmaniasis. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[31]  A. Spiers Clinical manifestations of chronic granulocytic leukemia. , 1995, Seminars in oncology.

[32]  N. Van Rooijen,et al.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.

[33]  S. Reed,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis. , 1994, The Journal of infectious diseases.

[34]  T. K. van den Berg,et al.  Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule , 1992, The Journal of experimental medicine.

[35]  G. Hussey,et al.  Miliary tuberculosis in children: a review of 94 cases , 1991, The Pediatric infectious disease journal.

[36]  S. Gordon,et al.  Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody , 1989, The Journal of experimental medicine.

[37]  P. Lambert,et al.  Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis. , 1984, Clinical and experimental immunology.

[38]  N. Reiner Host-parasite relationship in murine leishmaniasis: pathophysiological and immunological changes , 1982, Infection and immunity.

[39]  L. Moldawer,et al.  Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. , 2002, Critical care medicine.